CEL-SCI Corp. Prices Public Offering Of 1.11 Mln Shares At $9.00/shr
(RTTNews) - CEL-SCI Corp. (CVM), a clinical stage cancer immunotherapy company, announced the pricing of a public offering of about 1.11 million shares of its common stock at $9.00 per share.
Total gross proceeds from the offering, before deducting the placement agent's fees and other offering expenses, are expected to be approximately $10 million.
The offering is expected to close on August 29, 2025.
The company intends to use the net proceeds from the offering to fund the continued development of Multikine, general corporate purposes, and working capital.
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.